Ipsen Group Overview
- Founded
- 1929

- Status
- Public
- Employees
- 5,807

- Stock Symbol
- IPN

- Investments
- 23
- Share Price
- $88.95
- (As of Tuesday Closing)
Ipsen Group General Information
Description
Ipsen SA is a specialty and generic drug manufacturing company. The company's main therapeutic areas include oncology, endocrinology, neurosciences, and primary care. Ipsen maintains two segments: specialty care and primary care. The company derives most of its sales from the specialty care segment, with a vast majority of sales being generated in Western European countries. Ipsen's research and development strategy focus on peptides and toxins. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Contact Information
- 65, quai Georges Gorse
- 92100 Boulogne Billancourt
- France
Ipsen Group Stock Performance
(As of Tuesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$88.95 | $85.74 | $37.48 - $113.19 | $7.36B | 82.7M | 126K | -$0.65 |
Ipsen Group Financials Summary
In Thousands, USD |
TTM 30-Jun-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
---|---|---|---|---|
EV | 7,554,844 | 8,328,283 | 10,595,811 | 10,047,191 |
Revenue | 2,993,342 | 3,014,329 | 2,771,268 | 2,268,724 |
EBITDA | 181,810 | 129,296 | 757,957 | 546,402 |
Net Income | (54,079) | (56,756) | 459,636 | 307,090 |
Total Assets | 4,757,128 | 4,824,469 | 3,863,418 | 3,685,486 |
Total Debt | 1,106,450 | 955,843 | 383,894 | 434,532 |
Ipsen Group Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Ipsen Group‘s full profile, request access.
Request a free trialIpsen Group Comparisons
Industry
00000000
00000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialIpsen Group Competitors (37)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Pharming Group | Formerly VC-backed | Leiden, Netherlands | 000 | 00000 | 000000000 | 00000 |
000000000 | Private Equity-Backed | Milan, Italy | 0000 | 000000000000 | ||
000000 00000000000 | Corporation | Parma, Italy | 0000 | |||
000000 | Corporation | Paris, France | 000000 | 000000000000 | ||
00000 000000000000 | Private Equity-Backed | Atlanta, GA | 000 | 000.00 | 0&0 |
Ipsen Group Executive Team (27)
Ipsen Group Board Members (7)
Name | Representing | Role | Since |
---|---|---|---|
0000 00000000 | Ipsen Group | Board Member | 000 0000 |
00000 0000 | Ipsen Group | Chief Executive Officer & Board Member | 000 0000 |
00000 00000000 | Self | Board Member | 000 0000 |
0000 00 0000000 | Self | Chairman of the Board of Directors | 000 0000 |
0000000 000000 | Ipsen Group | General Secretary & Board Member | 000 0000 |
Ipsen Group Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialIpsen Group Investments & Acquisitions (23)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000000000 00000000 | 18-Apr-2019 | 000000000000000000 | 00.000 | Biotechnology | 00000 0000 |
000000 (0000 00000 | 08-May-2017 | 000000000 00000 00 | 000.00 | Buildings and Property | 00000 0000 |
000000000 00000000 | 03-Apr-2017 | 000000000 00000 00 | 00.000 | Buildings and Property | 00000 0000 |
000000 00000000000 | 16-Feb-2017 | 000000000 | 0000 | Biotechnology | |
Akkadeas Pharma | 31-Jan-2017 | Secondary Transaction - Private | Food Products |
Ipsen Group Subsidiaries (4)
Company Name | Industry | Location | Founded |
---|---|---|---|
Clementia Pharmaceuticals | Biotechnology | Montreal, Canada | 2010 |
000000 00000000000 | Drug Discovery | London, United Kingdom | 0000 |
00000 000000000000 | Biotechnology | Basking Ridge, NJ | 0000 |
00000 00000000 | Venture Capital | Boulogne Billancourt, France |
Ipsen Group Exits (6)
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
000000 00000000000 | 16-Feb-2017 | 000000000 | 0000 | Completed |
|
00000 000000000000 | 13-Aug-2015 | 00000 00000 00 | 0000 | Completed |
|
000000 00000000000 | 13-Aug-2015 | 00000 00000 00 | 0000 | Completed |
|
000000 00000000000 | 29-Jul-2013 | 00000 00000 00 | 0000 | Completed |
|
Radius Health | 16-Dec-2011 | Later Stage VC | 000.00 | Completed |
|